Insulin Glargine
60 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
60
Total Reports
10
Deaths Reported
1670.0%
Death Rate
Active Ingredients
Insulin Glargine
Administration Routes
UnknownSubcutaneousParenteral
Species Affected
Cat 58
Dog 2
Most Affected Breeds
Domestic Shorthair 34
Domestic Longhair 4
Cat (unknown) 4
Maine Coon 4
Domestic Mediumhair 3
Siamese 2
American Shorthair 2
Spitz - German Pomeranian 1
Domestic (unspecified) 1
Persian 1
Most Reported Reactions
Hypoglycaemia 14
Ketosis 14
Lethargy (see also Central nervous system depression in Neurological) 13
Hyperglycaemia 12
Diabetic ketoacidosis 11
Weight loss 10
Death by euthanasia 10
Diarrhoea 9
Not eating 8
Decreased appetite 7
Vomiting 6
Dehydration 6
Outcome Breakdown
Outcome Unknown
19 (32.2%)
Recovered/Normal
15 (25.4%)
Ongoing
13 (22.0%)
Euthanized
10 (16.9%)
Recovered with Sequela
2 (3.4%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.